FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 203 filers reported holding FIBROGEN INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |